Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nortriptyline in Functional Dyspepsia
NCT03652571Phase 3Terminated
- Sponsor
- Maastricht University Medical Center+
- Start
- Sep 2018
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional dyspepsia (FD) comparing Nortriptyline with Placebo (2 arms). Primary endpoint: Symptom response at 12 weeks. Started Sep 2018; status: terminated.
02
Drugs
nortriptyline
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT03652571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03652571.